Top

Published in:

01-11-2009 | Original Article

Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus

Authors: Parasar Ghosh, Amresh Kumar, Sudeep Kumar, Amita Aggarwal, Nakul Sinha, Ramnath Misra

Published in: Clinical Rheumatology | Issue 11/2009

Abstract

Patients with systemic lupus erythematosus (SLE), especially Asian Indians, are at increased risk of developing premature atherosclerosis. To find out the prevalence and predictors of carotid intima-medial thickness (IMT) and brachial artery flow-mediated dilatation (FMD). Endothelial dysfunction was assessed by FMD in brachial artery and IMT was measured in common carotid artery in SLE patients and healthy controls. Sixty SLE patients (mean age 31 ± 9 years) and 38 healthy controls (mean age 34 ± 6 years) were included. The IMT was higher in SLE patients as compared to controls (0.49 ± 0.08 mm vs. 0.39 ± 0.05 mm, p < 0.0001). SLE and damage were independent predictors of abnormal IMT. FMD was impaired in SLE patients compared to controls (9.97% vs. 18.97%, p < 0.00001). None of the classical cardiovascular risk factors were predictors of FMD or abnormal IMT. Indian patients with SLE have higher prevalence of subclinical atherosclerosis and endothelial dysfunction. Presence of damage was associated with abnormal IMT in SLE patients.

Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221–225PubMedCrossRef

Bjornadal L, Yin L, Granath F, Klareskog L, Ekbom A (2004) Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964–95. J Rheumatol 31:713–719PubMed

Esdaile JM, Abrahamowicz M, Grodzicky T et al (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44:2331–2337PubMedCrossRef

Manzi S, Meilahn EN, Rairie JE et al (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 145:408–415PubMed

Vita JA, Keaney JF Jr, Larson MG et al (2004) Brachial artery vasodilator function and systemic inflammation in the Framingham offspring study. Circulation 110:3604–3609PubMedCrossRef

Vlachoyiannopoulos PG, Kanellopoulos PG, Ioannidis JP, Tektonidou MG, Mastorakou I, Moutsopoulos HM (2003) Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology (Oxford) 42:645–651CrossRef

de Leeuw K, Sanders JS, Stegeman C, Smit A, Kallenberg CG, Bijl M (2005) Accelerated atherosclerosis in patients with Wegener's granulomatosis. Ann Rheum Dis 64:753–759PubMedCrossRef

Petri M, Lakatta C, Magder L, Goldman D (1994) Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 96:254–259PubMedCrossRef

Roman MJ, Shanker BA, Davis A et al (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349:2399–2406PubMedCrossRef

10.

Greenland P, Abrams J, Aurigemma GP et al (2000) Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 101:E16–E22PubMed

11.

Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE (1997) Common carotid intima–media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 96:1432–1437PubMed

12.

Chambless LE, Heiss G, Folsom AR et al (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987–1993. Am J Epidemiol 146:483–494PubMed

13.

Hodis HN, Mack WJ, LaBree L et al (1998) The role of carotid arterial intima–media thickness in predicting clinical coronary events. Ann Intern Med 128:262–269PubMed

14.

O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14–22PubMedCrossRef

15.

Manzi S, Selzer F, Sutton-Tyrrell K et al (1999) Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 42:51–60PubMedCrossRef

16.

Selzer F, Sutton-Tyrrell K, Fitzgerald SG et al (2004) Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum 50:151–159PubMedCrossRef

17.

Piper MK, Raza K, Nuttall SL et al (2007) Impaired endothelial function in systemic lupus erythematosus. Lupus 16:84–88PubMedCrossRef

18.

Lima DS, Sato EI, Lima VC, Miranda F Jr, Hatta FH (2002) Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 29:292–297PubMed

19.

El-Magadmi M, Bodill H, Ahmad Y et al (2004) Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 110:399–404PubMedCrossRef

20.

Mohan V, Deepa R (2004) Risk factors for coronary artery disease in Indians. J Assoc Physicians India 52:95–97PubMed

21.

Enas EA, Yusuf S, Mehta JL (1992) Prevalence of coronary artery disease in Asian Indians. Am J Cardiol 70:945–949PubMedCrossRef

22.

McKeigue PM, Miller GJ, Marmot MG (1989) Coronary heart disease in South Asians overseas: a review. J Clin Epidemiol 42:597–609PubMedCrossRef

23.

Bhatt SP, Handa R, Gulati GS et al (2006) Atherosclerosis in Asian Indians with systemic lupus erythematosus. Scand J Rheumatol 35:128–132PubMedCrossRef

24.

Grover S, Sinha RP, Singh U, Tewari S, Aggarwal A, Misra R (2006) Subclinical atherosclerosis in rheumatoid arthritis in India. J Rheumatol 33:244–247PubMed

25.

Bahl VK, Sharma G (2001) Coping with syncope: tilt towards pacing. Indian Heart J 53:415–422PubMed

26.

Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef

27.

Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640PubMedCrossRef

28.

Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for Systemic Lupus Erythematosus. Arthritis Rheum 39:363–369PubMedCrossRef

29.

Sidhu PS, Desai SR (1997) A simple and reproducible method for assessing intimal–medial thickness of the common carotid artery. Br J Radiol 70:85–89PubMed

30.

Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265PubMedCrossRef

31.

Svenungsson E, Jensen-Urstad K, Heimburger M et al (2001) Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 104:1887–1893PubMedCrossRef

32.

Reichlin M, Fesmire J, Quintero-Del-Rio AI, Wolfson-Reichlin M (2002) Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus. Arthritis Rheum 46:2957–2963PubMedCrossRef

33.

Doria A, Shoenfeld Y, Wu R et al (2003) Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62:1071–1077PubMedCrossRef

34.

Souza AW, Hatta FS, Miranda F Jr, Sato EI (2005) Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors. Sao Paulo Med J 123:137–142PubMedCrossRef

35.

Jimenez S, Garcia-Criado MA, Tassies D et al (2005) Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology (Oxford) 44:756–761CrossRef

36.

Colombo BM, Murdaca G, Caiti M et al (2007) Intima–media thickness: a marker of accelerated atherosclerosis in women with systemic lupus erythematosus. Ann N Y Acad Sci 1108:121–126PubMedCrossRef

37.

Sato H, Miida T, Wada Y et al (2007) Atherosclerosis is accelerated in patients with long-term well-controlled systemic lupus erythematosus (SLE). Clin Chim Acta 385:35–42PubMedCrossRef

38.

Lopez LR, Salazar-Paramo M, Palafox-Sanchez C, Hurley BL, Matsuura E, Garcia-De La Torre I (2006) Oxidized low-density lipoprotein and beta2-glycoprotein in patients with systemic lupus erythematosus and increased carotid intima–media thickness: implications in autoimmune-mediated atherosclerosis. Lupus 15:80–86PubMedCrossRef

39.

Wolak T, Todosoui E, Szendro G et al (2004) Duplex study of the carotid and femoral arteries of patients with systemic lupus erythematosus: a controlled study. J Rheumatol 31:909–914PubMed

40.

Anderson TJ, Elstein E, Haber H, Charbonneau F (2000) Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol 35:60–66PubMedCrossRef

41.

Ghiadoni L, Magagna A, Versari D et al (2003) Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 41:1281–1286PubMedCrossRef

42.

Mancini GB, Henry GC, Macaya C et al (1996) Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (trial on reversing endothelial dysfunction) study. Circulation 94:258–265PubMed

43.

Sudhir K, MacGregor JS, Gupta M et al (1993) Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies. Circulation 87:931–938PubMed

44.

Kawamoto R, Ohtsuka N, Kusunoki T, Yorimitsu N (2008) An association between the estimated glomerular filtration rate and carotid atherosclerosis. Intern Med 47:391–398PubMedCrossRef

45.

Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN (2000) Abnormalities of endothelial function in patients with predialysis renal failure. Heart 83:205–209PubMedCrossRef

46.

Hashimoto M, Eto M, Akishita M et al (1999) Correlation between flow-mediated vasodilatation of the brachial artery and intima–media thickness in the carotid artery in men. Arterioscler Thromb Vasc Biol 19:2795–2800PubMed

47.

Urowitz MB, Ibanez D, Gladman DD (2007) Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 34:70–75PubMed

48.

Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513–519PubMedCrossRef

49.

Shah MA, Shah AM, Krishnan E (2009) Poor outcomes after acute myocardial infarction in systemic lupus erythematosus. J Rheumatol 36:570–575PubMedCrossRef

50.

Urowitz MB, Gladman DD (2008) The SLICC inception cohort for atherosclerosis. Curr Rheumatol Rep 10:281–285PubMedCrossRef

Title: Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus
Authors: Parasar Ghosh
Amresh Kumar
Sudeep Kumar
Amita Aggarwal
Nakul Sinha
Ramnath Misra
Publication date: 01-11-2009
Publisher: Springer-Verlag
Published in: Clinical Rheumatology / Issue 11/2009
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-009-1228-6

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2009

Relationship between historical height loss and vertebral fractures in postmenopausal women

Associated factors for falls and fear of falling in Japanese patients with rheumatoid arthritis

Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population

Measuring educational needs among patients with rheumatoid arthritis using the Dutch version of the Educational Needs Assessment Tool (DENAT)

Evaluation of pathergy test positivity in familial Mediterranean fever patients and comparison of clinical manifestations of FMF with Behçet’s disease

Acute bilateral phrenic neuropathy following treatment with adalimumab

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page